GUTS vs HELP

Fractyl Health, Inc. vs Cybin Inc. — Valuation Comparison 2026

GUTS

Biotechnology
Fractyl Health, Inc.
Quality
4.4
out of 10
Value Trap
20
SAFE
Price
$0.84
Last close
Models
9/13
Active
VS

HELP

Biotechnology
Cybin Inc.
Quality
6.0
out of 10
Value Trap
6
SAFE
Price
$4.49
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType GUTS Fair ValueGUTS Upside HELP Fair ValueHELP Upside
Bayesian DCF Intrinsic $0.28 -66.8% $2.27 -49.3%
Earnings Power Value Intrinsic $0.47 -32.7%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.87 -83.2%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for GUTS vs HELP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GUTS vs HELP — Which Stock Is More Undervalued?

HELP scores higher with a 6.0/10 quality rating vs GUTS's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Fractyl Health, Inc. (GUTS) and Cybin Inc. (HELP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GUTS currently trades at $0.84 with a QOC of 4.4/10, while HELP trades at $4.49 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).